Home › Funds › PFM Health Sciences, LP › PRAX

PFM Health Sciences, LP position in PRAX

PRAXIS PRECISION MEDICINES I · Health Care

PFM Health Sciences, LP reported holding 38,575 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$12.9M, representing 1.13% of its reported portfolio and ranking #31 among its reported holdings. PFM Health Sciences, LP has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)38.58K sh
Reported value held$12.91M
Portfolio Weight1.13%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's PRAX position evolved

PFM Health Sciences, LP first disclosed a stake in PRAX in Q3 2023 at 8,919,997 shares (US$15.3M). The position peaked in Q1 2024 at 477,605 shares, worth US$29.1M. Across 12 filings, PFM Health Sciences, LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 38,575 shares valued at US$12.9M — an increase of 3,137 shares quarter over quarter.. Notable position changes include a 93% trim in Q4 2023 (shares rose 174% over the following quarter), a 60% trim in Q3 2024 (shares rose 34% over the following quarter), a 49% trim in Q4 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.92M $15.25M New
Q4 2023 656.55K $14.63M Reduce
Q1 2024 477.61K $29.14M Reduce
Q2 2024 453.15K $18.74M Reduce
Q3 2024 183.09K $10.54M Reduce
Q4 2024 119.51K $9.20M Reduce
Q1 2025 160.87K $6.09M Add
Q2 2025 84.71K $3.56M Reduce
Q3 2025 60.58K $3.21M Reduce
Q4 2025 31.16K $9.18M Reduce
Q1 2026 35.44K $11.42M Add
Q2 2026 38.58K $12.91M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRAX and 13F data

PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 74 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRAX

All PRAX fund holders →

FAQ

How long has PFM Health Sciences, LP held PRAX?

PFM Health Sciences, LP has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in PRAX?

As of Q2 2026, PFM Health Sciences, LP holds 38.58K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $12.91M, representing 1.13% of its reported portfolio and ranking #31.

Has PFM Health Sciences, LP been buying or selling PRAX?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in PRAX. The position peaked in Q1 2024 at 477.61K shares.

Which other funds hold PRAX?

Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.